pharma · Steroid refractory Acute Graft versus host Disease · moderate to severe atopic dermatitis
Medac Gesellschaft fuer
Medac Gesellschaft fuer klinische Spezialpraeparate mbH
Medac Gesellschaft fuer clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- EU
- Programs
- 3
- Drugs
- 14
- Patents
- 0
Medac Gesellschaft fuer projects
3 ClinicalTrials.gov programs sponsored by Medac Gesellschaft fuer.
Medac Gesellschaft fuer has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
MC-MSC.1/aGvHD
Medac Gesellschaft fuer klinische Spezialpraeparate mbH
Steroid refractory Acute Graft versus host Disease
1 trial -
MC-MTX.18/AD
Medac Gesellschaft fuer klinische Spezialpraeparate mbH
moderate to severe atopic dermatitis
1 trial -
MC-FludT.18/QT
Medac Gesellschaft fuer klinische Spezialpraeparate mbH
Subjects with AML ( Acute myeloid leukaemia) or MDS (Myelodysplastic syndrome) undergoing allogeneic hematopoietic stem cell transplantation
1 trial
Frequently asked questions
How many clinical projects does Medac Gesellschaft fuer have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.